Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Early evidence suggests stem cell therapy, including eye drops and exosomes, may improve dry eye symptoms in Sjögren's syndrome, but more research is needed before it becomes a…
Yes, the FDA has approved Hadlima (adalimumab) for treating active ankylosing spondylitis in adults.
Yes, switching to a biosimilar maintains disease control in stable ankylosing spondylitis, with comparable efficacy and safety based on randomized trials and real-world data.
Research shows that itch severity in systemic sclerosis generally remains stable over time rather than improving or worsening significantly as the disease progresses.
Based on a large meta-analysis, about 4.5% of adults with lupus experience psychosis, with higher risk in those with active disease or certain antibodies.
Yes, efgartigimod helps improve symptoms in myasthenia gravis patients, with most studies showing clinically meaningful improvements in daily living scores and muscle strength.
Yes, people with myasthenia gravis have an increased risk of developing autoimmune encephalitis, likely due to shared autoimmune mechanisms and overlapping antibody targets.
Yes, complement inhibitors (eculizumab, ravulizumab, zilucoplan) significantly improve symptoms and daily functioning in AChR antibody-positive generalized myasthenia gravis…
Yes, mindfulness training, particularly Mindfulness Based Stress Reduction (MBSR), improves quality of life and reduces pain catastrophising in people with fibromyalgia, with…
For a walking program for adults with arthritis, Facebook was the most successful recruitment strategy, followed by radio advertisements and word of mouth.
About 54.4 million U.S. adults, or 22.7% of the adult population, currently have a provider-diagnosed case of arthritis.
About 67% of U.S. adults with arthritis engage in at least one type of physical activity, though many do not meet full health guidelines.
Arthritis Awareness Month is observed in May to bring attention to the condition and its impact on daily life.
Belimumab is approved for lupus nephritis and appears more effective than anifrolumab, which is not yet approved for this condition.
Biologics (e.g., anifrolumab, belimumab) and targeted drugs (e.g., telitacicept, upadacitinib) both treat SLE, but network meta-analyses show telitacicept may outperform…
Patients with rheumatoid arthritis have a higher risk of shingles compared to the general population, with a pooled proportion of about 6% and a 30% increased risk.
Yes, Hadlima (adalimumab) is FDA-approved for treating moderately to severely active rheumatoid arthritis in adults.
Yes, sinomenine reduces arthritis markers in animal studies for rheumatoid arthritis, as shown by meta-analyses and individual rodent studies.
RNA methylation, especially m6A, is increased in rheumatoid arthritis and may drive synovitis by altering gene expression in joint cells, with potential as a biomarker and…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.